Calcitriol Imparts Neuroprotection In Vitro to Midbrain Dopaminergic Neurons by Upregulating GDNF Expression

PLoS ONE

Volumn 8, Issue 4, 2013, Pages

  Orme, Rowan P ^a   Bhangal, Manminder S ^b   Fricker, Rosemary A ^a,b  

^a KEELE UNIVERSITY   (United Kingdom)

^b KEELE UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITRIOL; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; CALCITRIOL RECEPTOR; NEUROPROTECTIVE AGENT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL COUNT; CONCENTRATION RESPONSE; CONTROLLED STUDY; CULTURE MEDIUM; DOPAMINERGIC NERVE CELL; DRUG MECHANISM; EMBRYO; IN VITRO STUDY; MESENCEPHALON; NERVE CELL DIFFERENTIATION; NEUROPROTECTION; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; SIGNAL TRANSDUCTION; UPREGULATION; ANIMAL; CELL DIFFERENTIATION; DRUG EFFECTS; EMBRYOLOGY; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PRIMARY CELL CULTURE;

RATTUS;

ANIMALS; APOPTOSIS; CALCITRIOL; CELL DIFFERENTIATION; DOPAMINERGIC NEURONS; GENE EXPRESSION REGULATION; GLIAL CELL LINE-DERIVED NEUROTROPHIC FACTOR; MESENCEPHALON; NEUROPROTECTIVE AGENTS; PRIMARY CELL CULTURE; RATS; RECEPTORS, CALCITRIOL; SIGNAL TRANSDUCTION;

EID: 84876539226     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0062040     Document Type: Article

References (38)

1. Lin LF, Doherty DH, Lile JD, Bektesh S, Collins F, (1993) GDNF: A glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons. Science 260: 1130-1132.
2. Jones KR, Reichardt LF, (1990) Molecular cloning of a human gene that is a member of the nerve growth factor family. Proceedings of the National Academy of Sciences of the United States of America 87: 8060-8064.
3. Petrova P, Raibekas A, Pevsner J, Vigo N, Anafi M, et al. (2003) MANF: A new mesencephalic, astrocyte-derived neurotrophic factor with selectivity for dopaminergic neurons. Journal of Molecular Neuroscience 20: 173-188.
4. Grondin R, Zhang Z, Yi A, Cass WA, Maswood N, et al. (2002) Chronic, controlled GDNF infusion promotes structural and functional recovery in advanced parkinsonian monkeys. Brain 125: 2191-2201.
5. Kordower JH, Emborg ME, Bloch J, Ma SY, Chu Y, et al. (2000) Neurodegeneration prevented by lentiviral vector delivery of GDNF in primate models of parkinson's disease. Science 290: 767-773.
6. Gill SS, Patel NK, Hotton GR, O'Sullivan K, McCarter R, et al. (2003) Direct brain infusion of glial cell line-derived neurotrophic factor in parkinson disease. Nature Medicine 9: 589-595.
7. Slevin JT, Gerhardt GA, Smith CD, Gash DM, Kryscio R, et al. (2005) Improvement of bilateral motor functions in patients with parkinson disease through the unilateral intraputaminal infusion of glial cell line-derived neurotrophic factor. Journal of Neurosurgery 102: 216-222.
8. Nutt JG, Burchiel KJ, Comella CL, Jankovic J, Lang AE, et al. (2003) Randomized, double-blind trial of glial cell line-derived neurotrophic factor (GDNF) in PD. Neurology 60: 69-73.
9. Orme RP, Gates MA, Fricker-Gates RA, (2010) A multiplexed quantitative proteomics approach for investigating protein expression in the developing central nervous system. Journal of Neuroscience Methods 191: 75-82.
10. Bagga V, Dunnett SB, Fricker-Gates R, (2008) Ascorbic acid increases the number of dopamine neurons in vitro and in transplants to the 6-OHDA-lesioned rat brain. Cell Transplantation 17: 763-773.
11. Holder N, Hill J, (1991) Retinoic acid modifies development of the midbrain-hindbrain border and affects cranial ganglion formation in zebrafish embryos. Development 113: 1159-1170.
12. Norman AW, (2008) From vitamin D to hormone D: Fundamentals of the vitamin D endocrine system essential for good health. The American Journal of Clinical Nutrition 88: 491S-499S.
13. Naveilhan P, Neveu I, Wion D, Brachet P, (1996) 1,25-dihydroxyvitamin D3, an inducer of glial cell line-derived neurotrophic factor. Neuroreport 7: 2171-2175.
14. Diesel B, Radermacher J, Bureik M, Bernhardt R, Seifert M, et al. (2005) Vitamin D(3) metabolism in human glioblastoma multiforme: Functionality of CYP27B1 splice variants, metabolism of calcidiol, and effect of calcitriol. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 11: 5370-5380.
15. Carlberg C, (2003) Current understanding of the function of the nuclear vitamin D receptor in response to its natural and synthetic ligands. Recent Results in Cancer Research 164: 29-42.
16. Gonzalez MM, Samenfeld P, Perakyla M, Carlberg C, (2003) Corepressor excess shifts the two-side chain vitamin D analog gemini from an agonist to an inverse agonist of the vitamin D receptor. Molecular Endocrinology 17: 2028-2038.
17. Dace A, Martin-el Yazidi C, Bonne J, Planells R, Torresani J, (1997) Calcitriol is a positive effector of adipose differentiation in the OB 17 cell line: Relationship with the adipogenic action of triiodothyronine. Biochemical and Biophysical Research Communications 232: 771-776.
18. Hosomi J, Hosoi J, Abe E, Suda T, Kuroki T, (1983) Regulation of terminal differentiation of cultured mouse epidermal cells by 1 alpha,25-dihydroxyvitamin D3. Endocrinology 113: 1950-1957.
19. An BS, Tavera-Mendoza LE, Dimitrov V, Wang X, Calderon MR, et al. (2010) Stimulation of Sirt1-regulated FoxO protein function by the ligand-bound vitamin D receptor. Molecular and Cellular Biology 30: 4890-4900.
20. Sanchez B, Lopez-Martin E, Segura C, Labandeira-Garcia JL, Perez-Fernandez R, (2002) 1,25-dihydroxyvitamin D(3) increases striatal GDNF mRNA and protein expression in adult rats. Molecular Brain Research 108: 143-146.
21. Wang Y, Chiang YH, Su TP, Hayashi T, Morales M, et al. (2000) Vitamin D(3) attenuates cortical infarction induced by middle cerebral arterial ligation in rats. Neuropharmacology 39: 873-880.
22. Wang JY, Wu JN, Cherng TL, Hoffer BJ, Chen HH, et al. (2001) Vitamin D(3) attenuates 6-hydroxydopamine-induced neurotoxicity in rats. Brain Research 904: 67-75.
23. Roussa E, Krieglstein K, (2004) GDNF promotes neuronal differentiation and dopaminergic development of mouse mesencephalic neurospheres. Neuroscience Letters 361: 52-55.
24. Barnett MW, Fisher CE, Perona-Wright G, Davies JA, (2002) Signalling by glial cell line-derived neurotrophic factor (GDNF) requires heparan sulphate glycosaminoglycan. Journal of Cell Science 115: 4495-4503.
25. Iwase T, Jung CG, Bae H, Zhang M, Soliven B, (2005) Glial cell line-derived neurotrophic factor-induced signaling in schwann cells. Journal of Neurochemistry 94: 1488-1499.
26. Burkert R, McGrath J, Eyles D, (2003) Vitamin D receptor expression in the embryonic rat brain. Neuroscience Research Communications 33: 63-71.
27. Bishop JE, Collins ED, Okamura WH, Norman AW, (1994) Profile of ligand specificity of the vitamin D binding protein for 1 alpha,25-dihydroxyvitamin D3 and its analogs. Journal of Bone and Mineral Research 9: 1277-1288.
28. Fau CE, Fau ZW, Freed CR, (1997) GDNF improves survival and reduces apoptosis in human embryonic dopaminergic neurons in vitro. Cell and Tissue Research 289: 207-210.
29. Piltonen M, Bespalov MM, Ervasti D, Matilainen T, Sidorova YA, et al. (2009) Heparin-binding determinants of GDNF reduce its tissue distribution but are beneficial for the protection of nigral dopaminergic neurons. Experimental Neurology 219: 499-506.
30. Lang AE, Gill S, Patel NK, Lozano A, Nutt JG, et al. (2006) Randomized controlled trial of intraputamenal glial cell line-derived neurotrophic factor infusion in parkinson disease. Annals of Neurology 59: 459-466.
31. Salvatore MF, Ai Y, Fischer B, Zhang AM, Grondin RC, et al. (2006) Point source concentration of GDNF may explain failure of phase II clinical trial. Experimental Neurology 202: 497-505.
32. Zhou Q, Boado RJ, Lu JZ, Hui EK, Pardridge WM, (2010) Monoclonal antibody-glial-derived neurotrophic factor fusion protein penetrates the blood-brain barrier in the mouse. Drug Metabolism and Disposition 38: 566-572.
33. Eyles DW, Smith S, Kinobe R, Hewison M, McGrath JJ, (2005) Distribution of the vitamin D receptor and 1α-hydroxylase in human brain. Journal of Chemical Neuroanatomy 29: 21-30.
34. Kim J, Kim Y, Song C, Yoon I, Park J, et al. (2005) Association of vitamin D receptor gene polymorphism and parkinson's disease in koreans. J Korean Med Sci 20: 495-498.
35. Butler MW, Burt A, Edwards TL, Zuchner S, Scott WK, et al. (2011) Vitamin D receptor gene as a candidate gene for parkinson disease. Annals of Human Genetics 75: 201-210.
36. Evatt ML, DeLong MR, Khazai N, Rosen A, Triche S, et al. (2008) Prevalence of vitamin D insufficiency in patients with parkinson disease and alzheimer disease. Archives of Neurology 65: 1348-1352.
37. Sato Y, Kikuyama M, Oizumi K, (1997) High prevalence of vitamin D deficiency and reduced bone mass in parkinson's disease. Neurology 49: 1273-1278.
38. Kosakai A, Ito D, Nihei Y, Yamashita S, Okada Y, et al. (2011) Degeneration of mesencephalic dopaminergic neurons in klotho mouse related to vitamin D exposure. Brain Research 1382: 109-117.